These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3904613)

  • 1. Candida albicans: biology, genetics, and pathogenicity.
    Shepherd MG; Poulter RT; Sullivan PA
    Annu Rev Microbiol; 1985; 39():579-614. PubMed ID: 3904613
    [No Abstract]   [Full Text] [Related]  

  • 2. Candida albicans molecular biology reaches its maturity.
    Larriba G; Rubio Coque JJ; Ciudad A; Andaluz E
    Int Microbiol; 2000 Dec; 3(4):247-52. PubMed ID: 11334309
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of antifungal polyene antibiotics on adhesion of Candida albicans to the epithelium of the oral cavity in vitro].
    Macura AB; Pawlik B; Dwernicka B
    Med Dosw Mikrobiol; 1988; 40(4):238-43. PubMed ID: 3073283
    [No Abstract]   [Full Text] [Related]  

  • 4. Dosage-dependent roles of the Cwt1 transcription factor for cell wall architecture, morphogenesis, drug sensitivity and virulence in Candida albicans.
    Moreno I; Martinez-Esparza M; Laforet LC; Sentandreu R; Ernst JF; Valentin E
    Yeast; 2010 Feb; 27(2):77-87. PubMed ID: 19908200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida albicans: fundamental research on an opportunistic human pathogen.
    Calderone R; Odds FC; Boekhout T
    FEMS Yeast Res; 2009 Oct; 9(7):971-2. PubMed ID: 19845040
    [No Abstract]   [Full Text] [Related]  

  • 6. Disruption of the intestinal mucosal barrier in Candida albicans infections.
    Yan L; Yang C; Tang J
    Microbiol Res; 2013 Aug; 168(7):389-95. PubMed ID: 23545353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity determinants of Candida albicans: potential targets for immunotherapy?
    Matthews RC
    Microbiology (Reading); 1994 Jul; 140 ( Pt 7)():1505-11. PubMed ID: 8075793
    [No Abstract]   [Full Text] [Related]  

  • 8. Homozygosity at the MTL locus in clinical strains of Candida albicans: karyotypic rearrangements and tetraploid formation.
    Legrand M; Lephart P; Forche A; Mueller FM; Walsh T; Magee PT; Magee BB
    Mol Microbiol; 2004 Jun; 52(5):1451-62. PubMed ID: 15165246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of oxidative stress tolerance resulted in reduced ability to undergo morphologic transitions and decreased pathogenicity in a t-butylhydroperoxide-tolerant mutant of Candida albicans.
    Fekete A; Emri T; Gyetvai A; Gazdag Z; Pesti M; Varga Z; Balla J; Cserháti C; Emody L; Gergely L; Pócsi I
    FEMS Yeast Res; 2007 Sep; 7(6):834-47. PubMed ID: 17498215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibility of Candida albicans in biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Presterl E
    Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of the Candida albicans cell wall during commensalism and infection.
    Gow NA; Hube B
    Curr Opin Microbiol; 2012 Aug; 15(4):406-12. PubMed ID: 22609181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of DNA microarray technology and gene expression profiles to investigate the pathogenesis, cell biology, antifungal susceptibility and diagnosis of Candida albicans.
    Garaizar J; Brena S; Bikandi J; Rementeria A; Pontón J
    FEMS Yeast Res; 2006 Nov; 6(7):987-98. PubMed ID: 17042748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk.
    Poulain D; Jouault T
    Curr Opin Microbiol; 2004 Aug; 7(4):342-9. PubMed ID: 15358252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four cases of Candida albicans infections with isolates developing pink colonies on CHROMagar Candida plates.
    Saunte DM; Klingspor L; Jalal S; Arnau J; Arendrup MC
    Mycoses; 2005 Nov; 48(6):378-81. PubMed ID: 16262872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida albicans: genetics, dimorphism and pathogenicity.
    Molero G; Díez-Orejas R; Navarro-García F; Monteoliva L; Pla J; Gil C; Sánchez-Pérez M; Nombela C
    Int Microbiol; 1998 Jun; 1(2):95-106. PubMed ID: 10943347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pga13 in Candida albicans is localized in the cell wall and influences cell surface properties, morphogenesis and virulence.
    Gelis S; de Groot PW; Castillo L; Moragues MD; Sentandreu R; Gómez MM; Valentín E
    Fungal Genet Biol; 2012 Apr; 49(4):322-31. PubMed ID: 22343036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human fungal pathogen Candida albicans in the postgenomic era: an overview.
    Kabir MA; Hussain MA
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):121-34. PubMed ID: 19622061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione.
    Gyetvai A; Emri T; Fekete A; Varga Z; Gazdag Z; Pesti M; Belágyi J; Emõdy L; Pócsi I; Lenkey B
    FEMS Yeast Res; 2007 Mar; 7(2):265-75. PubMed ID: 17266730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells.
    Katragkou A; Simitsopoulou M; Chatzimoschou A; Georgiadou E; Walsh TJ; Roilides E
    Cytokine; 2011 Sep; 55(3):330-4. PubMed ID: 21641233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida albicans biology and pathogenicity: insights from proteomics.
    Pitarch A; Nombela C; Gil C
    Methods Biochem Anal; 2006; 49():285-330. PubMed ID: 16929685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.